Allspring Global Investments
STIM icon

Allspring Global Investments’s Neuronetics STIM Stock Holding History

Allspring Global Investments’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-83,187
Closed -$112K – 2704
2023
Q3 		$112K Sell
83,187
-160,730
-66% -$282K ﹤0.01% 1958
2023
Q2 		$524K Buy
243,917
+12,910
+6% +$31.3K ﹤0.01% 1557
2023
Q1 		$672K Buy
231,007
+4,407
+2% +$22.2K ﹤0.01% 1520
2022
Q4 		$1.56M Buy
226,600
+1,321
+0.6% +$6.24K ﹤0.01% 1314
2022
Q3 		$716K Sell
225,279
-1,766
-0.8% -$6.42K ﹤0.01% 1504
2022
Q2 		$728K Sell
227,045
-10,477
-4% -$30.4K ﹤0.01% 1499
2022
Q1 		$719K Buy
237,522
+62,552
+36% +$211K ﹤0.01% 2059
2021
Q4 		$780K Buy
+174,970
New +$857K ﹤0.01% 2087

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments's STIM Position: Q4 2023 in Review

Allspring Global Investments sold out of Neuronetics (STIM) in Q4 2023, closing a stake of 83,187 shares — an estimated $112K sold.

Allspring Global Investments first reported a position in STIM in Q4 2021 and held it in 8 quarters. The position peaked at $1.56M in Q4 2022. 66 funds tracked by Wall St. Rank hold STIM as of Q4 2023.

  • Allspring Global Investments reported no remaining Neuronetics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 83,187 Neuronetics shares in Q4 2023, an estimated $112K.
  • Allspring Global Investments first reported a position in Neuronetics in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Neuronetics position peaked at $1.56M in Q4 2022.
  • 66 funds tracked by Wall St. Rank held Neuronetics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.